Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia

J Neurochem. 2011 Jan;116(2):217-26. doi: 10.1111/j.1471-4159.2010.07095.x. Epub 2010 Dec 2.

Abstract

Astrogliosis occurs after brain ischemia, and excessive astrogliosis can devastate the neuronal recovery. Previous reports show that galectin-1 (Gal-1) regulates proliferation of several cell types and plays an important role after nervous system injuries. Here, we found that expression of Gal-1 was remarkably up-regulated in activated astrocytes around ischemic infarct. Furthermore, under ischemic conditions either in vitro or in vivo, Gal-1 was found to inhibit the proliferation of astrocytes in a dose-dependent manner, attenuate astrogliosis and down-regulate the astrogliosis associated expression of nitric oxide synthase and interleukin-1β after the ischemia. All these changes were blocked by lactose, suggesting a lectin dependent manner of Gal-1's function. Moreover, 7-day Gal-1 treatment reduced apoptosis of neurons, decreased brain infarction volume and improved neurological function induced by the ischemia. Together, these findings indicate that through reducing astrogliosis related damages, Gal-1 is a potential therapeutical target for attenuating neuronal damage and promoting recovery of brain ischemia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism*
  • Astrocytes / pathology
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism*
  • Cells, Cultured
  • Disease Models, Animal
  • Galectin 1 / biosynthesis
  • Galectin 1 / physiology*
  • Galectin 1 / therapeutic use*
  • Gliosis / drug therapy*
  • Gliosis / metabolism*
  • Gliosis / pathology
  • Male
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Recovery of Function / physiology*
  • Up-Regulation / physiology

Substances

  • Galectin 1